Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Working Capital Changes: 2018-2024

Historic Other Working Capital Changes for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to -$6.9 million.

  • ADC Therapeutics' Other Working Capital Changes was N/A to $13.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $23.0 million, marking a year-over-year change of. This contributed to the annual value of -$6.9 million for FY2024, which is 193.70% down from last year.
  • As of FY2024, ADC Therapeutics' Other Working Capital Changes stood at -$6.9 million, which was down 193.70% from $7.4 million recorded in FY2023.
  • In the past 5 years, ADC Therapeutics' Other Working Capital Changes ranged from a high of $11.5 million in FY2022 and a low of -$6.9 million during FY2024.
  • Moreover, its 3-year median value for Other Working Capital Changes was $7.4 million (2023), whereas its average is $4.0 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 280.37% in 2022, then crashed by 193.70% in 2024.
  • Over the past 5 years, ADC Therapeutics' Other Working Capital Changes (Yearly) stood at -$4.5 million in 2020, then tumbled by 41.09% to -$6.4 million in 2021, then surged by 280.37% to $11.5 million in 2022, then tumbled by 35.53% to $7.4 million in 2023, then plummeted by 193.70% to -$6.9 million in 2024.